71 related articles for article (PubMed ID: 18337085)
1. Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data.
Kittaka N; Takemasa I; Takeda Y; Marubashi S; Nagano H; Umeshita K; Dono K; Matsubara K; Matsuura N; Monden M
Eur J Cancer; 2008 Apr; 44(6):885-97. PubMed ID: 18337085
[TBL] [Abstract][Full Text] [Related]
2. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
[TBL] [Abstract][Full Text] [Related]
3. [Comparative genomic classification of human hepatocellular carcinoma].
Kaposi-Novák P
Magy Onkol; 2009 Mar; 53(1):61-7. PubMed ID: 19318328
[TBL] [Abstract][Full Text] [Related]
4. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
5. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
[TBL] [Abstract][Full Text] [Related]
6. OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci.
Su WH; Chao CC; Yeh SH; Chen DS; Chen PJ; Jou YS
Nucleic Acids Res; 2007 Jan; 35(Database issue):D727-31. PubMed ID: 17098932
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
[TBL] [Abstract][Full Text] [Related]
8. Functional genomics of hepatocellular carcinoma.
Thorgeirsson SS; Lee JS; Grisham JW
Hepatology; 2006 Feb; 43(2 Suppl 1):S145-50. PubMed ID: 16447291
[TBL] [Abstract][Full Text] [Related]
9. Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: multicentric occurrence or intrahepatic metastasis?
Nakata T; Seki N; Miwa S; Kobayashi A; Soeda J; Nimura Y; Kawasaki S; Miyagawa S
Hepatogastroenterology; 2008; 55(84):865-72. PubMed ID: 18705285
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
Wong QW; Lung RW; Law PT; Lai PB; Chan KY; To KF; Wong N
Gastroenterology; 2008 Jul; 135(1):257-69. PubMed ID: 18555017
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.
Tsukamoto Y; Uchida T; Karnan S; Noguchi T; Nguyen LT; Tanigawa M; Takeuchi I; Matsuura K; Hijiya N; Nakada C; Kishida T; Kawahara K; Ito H; Murakami K; Fujioka T; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):471-82. PubMed ID: 18798223
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
13. The knockdown of endogenous replication factor C4 decreases the growth and enhances the chemosensitivity of hepatocellular carcinoma cells.
Arai M; Kondoh N; Imazeki N; Hada A; Hatsuse K; Matsubara O; Yamamoto M
Liver Int; 2009 Jan; 29(1):55-62. PubMed ID: 18492021
[TBL] [Abstract][Full Text] [Related]
14. Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures.
Braconi C; Meng F; Swenson E; Khrapenko L; Huang N; Patel T
Cancer; 2009 Aug; 115(16):3738-48. PubMed ID: 19514085
[TBL] [Abstract][Full Text] [Related]
15. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
[TBL] [Abstract][Full Text] [Related]
16. Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.
Woo HG; Park ES; Cheon JH; Kim JH; Lee JS; Park BJ; Kim W; Park SC; Chung YJ; Kim BG; Yoon JH; Lee HS; Kim CY; Yi NJ; Suh KS; Lee KU; Chu IS; Roskams T; Thorgeirsson SS; Kim YJ
Clin Cancer Res; 2008 Apr; 14(7):2056-64. PubMed ID: 18381945
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
Petersson S; Shubbar E; Enerbäck L; Enerbäck C
Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
[TBL] [Abstract][Full Text] [Related]
18. Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma.
Tanaka Y; Kanai F; Tada M; Tateishi R; Sanada M; Nannya Y; Ohta M; Asaoka Y; Seto M; Shiina S; Yoshida H; Kawabe T; Yokosuka O; Ogawa S; Omata M
J Hepatol; 2008 Nov; 49(5):746-57. PubMed ID: 18752864
[TBL] [Abstract][Full Text] [Related]
19. Intrahepatic gene expression in human alcoholic hepatitis.
Seth D; Gorrell MD; Cordoba S; McCaughan GW; Haber PS
J Hepatol; 2006 Aug; 45(2):306-20. PubMed ID: 16797773
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]